Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
0.8676
+0.0375 (4.52%)
Sep 18, 2025, 3:35 PM EDT - Market open
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $112.07 million as of September 18, 2025. Its market cap has decreased by -34.96% in one year.
Market Cap
112.07M
Enterprise Value
49.37M
1-Year Change
-34.96%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has increased from $62.00M to $112.07M, an increase of 80.76%. That is a compound annual growth rate of 4.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 106.20M | -10.61% |
| Dec 31, 2024 | 118.80M | 7.71% |
| Dec 29, 2023 | 110.30M | 64.87% |
| Dec 30, 2022 | 66.90M | -66.98% |
| Dec 31, 2021 | 202.60M | 197.94% |
| Dec 31, 2020 | 68.00M | 375.52% |
| Dec 31, 2019 | 14.30M | 146.55% |
| Dec 31, 2018 | 5.80M | -17.14% |
| Dec 29, 2017 | 7.00M | 32.08% |
| Dec 30, 2016 | 5.30M | -45.36% |
| Dec 31, 2015 | 9.70M | -72.36% |
| Dec 31, 2014 | 35.10M | -16.03% |
| Dec 31, 2013 | 41.80M | -17.06% |
| Dec 31, 2012 | 50.40M | -18.71% |
| Nov 8, 2012 | 62.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.62B |
| Johnson & Johnson | 425.43B |
| AbbVie | 383.82B |
| UnitedHealth Group | 307.92B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 231.22B |